Foto de SOFÍA MARÍA

SOFÍA MARÍA
TORIBIO CASTELLÓ

Investigadora Predoctoral

Profila Argitalpenak Lankidetza

Argitalpenak (6) SOFÍA MARÍA TORIBIO CASTELLÓ argitalpenak

2025

Cost-Effectiveness of Elranatamab Versus Current Therapies for the Management of Patients with Triple-Class Exposed, Relapsed and Refractory Multiple Myeloma, Including Other Bispecific and Physician’s Choice of Treatment in Spain
Oncology and Therapy, Vol. 13, Núm. 2, pp. 381-395

2023

Mutational Profile Enables the Identification of a High-Risk Subgroup in Myelodysplastic Syndromes with Isolated Trisomy 8
Cancers, Vol. 15, Núm. 15

2022

MDS-454 SF3B1 and DNMT3A Mutations Might Play a Role in Poor Prognosis and AML Progression in Patients With Isolated del(5q) MDS
Clinical Lymphoma, Myeloma and Leukemia, Vol. 22, pp. S316
MDS-472 STAG2 and SRSF2 Mutations Might Define Prognosis of MDS Patients With Isolated Trisomy 8
Clinical Lymphoma, Myeloma and Leukemia, Vol. 22, pp. S316-S317

2021

NAIP expression increases in a rat model of liver mass restoration
Journal of Molecular Histology, Vol. 52, Núm. 1, pp. 113-123

2018

Inhibitor of apoptosis proteins, NAIP, cIAP1 and cIAP2 expression during macrophage differentiation and M1/M2 polarization
PLoS ONE, Vol. 13, Núm. 3